Transasia Bio-Medicals unveils SAVIOUR – a blood donation app to connect patients and donors

Share on facebook
Share on twitter
Share on linkedin
SAVIOUR is the first in India to be on both Google Play & App Store; complete anonymity between patient and donor prevents exploitation/unethical practices like blood for money

Press release for immediate publication:
Transasia Bio-Medicals unveils SAVIOUR – a blood donation app to connect patients and donors
SAVIOUR is the first in India to be on both Google Play & App Store; complete anonymity between patient and donor prevents exploitation/unethical practices like blood for money

Mumbai, June 13th, 2019: On the occasion of World Blood Donors Day, Transasia Bio-Medicals Ltd., India’s leading In-vitro Diagnostic Company, today unveiled ‘SAVIOUR’, a location based blood donation app that is available free to everyone. It is the first in India to be on both Google Play and App Store. The new app is likely to empower those who have the resources to acquire blood but lose out on timely help due to inadequate blood bank infrastructure. It connects patients to the nearest donors, and notifies the patient in real-time on the number of donors who accept the request. Additionally, it sends out notifications to the registered donors on the need for blood based on their type. Reminders sent by the app, ensure that the donors do not forget about their commitment. Once a donation has been made, a donor is not advised to donate blood in the recovery period. At this time, the app goes into a precautionary dormant state, in order to ensure complete safety of the donor. Moreover, the app makes it very convenient for donors; they just need to check-in at the nearest hospital through the app, a step that helps save time and ensure credibility. Donors are incentivized with personal goodwill points, based on the number of donations and lives saved.

In his comments, Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd., said, “Blood donation saves millions of lives. The new app is another by Transasia in line with our mission since inception, to make healthcare affordable and address the limited access to quality medical infrastructure for the masses. As the name rightly connotes, ‘SAVIOUR’ has been developed with a vision to empower both donors and patients and to save them from unethical practices which have led to corruption and exploitation of the needy. We will invest heavily in promotion of the new app to facilitate its widespread use and save as many lives as possible. I would like to thank my team for their efforts in developing this app and ensuring it addresses most gaps with existing alternatives. I urge the healthy youth of our nation to register on the app as donors and share the light of their life.”

According to WHO estimates, blood donation by 1% of the population is the minimum needed to meet a country’s basic blood requirements. In 2016-17, India’s blood collection fell 15% over previous year, or 1.9 million units short of the 1% benchmark. The WHO norm, however, is based on global averages and does not take into account India-specific factors and disease burden. As per Industry reports, in 2016-17, over 6.57 lakh units of blood and its products were discarded. 50% of the wasted units was Plasma which has a longer shelf life as compared to whole blood and red blood cells that have to be used within 35 days.
____________________________________________________________________________________________________

About Transasia Bio-Medicals Ltd. :
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. It provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with 65,000 equipment installed across India. Transasia boasts of 250+ service engineers, 400+ sales and marketing team, 24 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood

analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, which are among the best globally. It has been conferred ‘India Medical Device – Export Company of the Year 2017’ and the ‘Global Growth Company-2014’ by the World Economic Forum amongst many others. Headquartered in Mumbai, Transasia is a part of the global Transasia-Erba group. The group has spread its
footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. Transasia-Erba Group’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables. Today, the group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com

For editorial queries only contact:
Anurag/ Shruti of PRHUB anurag@prhub.com/9322501136,shrutiu@prhub.com/8108981953